Latest News

Important COVID-19 information for those with asthma and/or allergies

As COVID-19 continues to spread throughout the United States and the world, allergists are hearing from their patients – those with allergies and especially those suffering from asthma. They are worried that having asthma means they’re at increased risk for developing symptoms from COVID-19 if they are exposed. They also wonder if their symptoms will be more dangerous if they have the virus. In addition, a recent announcement regarding a shortage of albuterol has increased anxiety throughout the country.  

A message to asthma sufferers about a shortage of albuterol metered dose inhalers

ARLINGTON HEIGHTS, Ill (March 20, 2020) - Certain areas of the country are experiencing shortages of albuterol inhalers. The shortage will probably spread throughout the U.S., although it is not a production problem. The shortage is occurring because of the increased use of albuterol inhalers in hospitals for COVID-19 and suspected COVID-19 patients to help with respiratory issues.  There is a concern that nebulizers used on patients with COVID-19 in the hospital could spread the virus in the air. But the possible risk is to hospitalized patients with COVID-19 – not to patients using their nebulizer at home as directed.

Important information about COVID-19 for those with asthma

ARLINGTON HEIGHTS, Ill (March 12, 2020) – The recent pandemic outbreak of COVID-19 is creating concern and uncertainty for many people, especially those who suffer from asthma. The elderly, and anyone with severe asthma, immunodeficiency or other chronic conditions where the immune system may be compromised, are the most susceptible to viral infections in general and must take precautions against COVID-19.